Aloracetam

Aloracetam

Systematic (IUPAC) name
N-[2-(3-formyl-2,5-dimethylpyrrol-1-yl)ethyl]acetamide
Clinical data
Legal status	Unscheduled
Identifiers
CAS Registry Number	119610-26-3 Y
ATC code	None
PubChem	CID 178134
ChemSpider	155069 Y
UNII	U0RKZ75D0T Y
ChEMBL	CHEMBL2104637
Chemical data
Formula	C11H16N2O2
Molecular mass	208.257 g/mol
SMILES CC1=CC(=C(N1CCNC(=O)C)C)C=O
InChI InChI=1S/C11H16N2O2/c1-8-6-11(7-14)9(2)13(8)5-4-12-10(3)15/h6-7H,4-5H2,1-3H3,(H,12,15)  Y Key:ZUQSGZULKDDMEW-UHFFFAOYSA-N  Y
Y (what is this?)  (verify)

Aloracetam is a nootropic drug of the racetam family, developed by Aventis for the treatment of Alzheimer's disease.^[1]

Aloracetam is not actually of the racetam family as it lacks a pyrrolidone ring.

See also

• Piracetam

References

1. ↑ Fischer F, Matthisson M, Herrling P. List of Drugs in Development for Neurodegenerative Diseases. Neurodegenerative Diseases 2004;1:50–70.